BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35129994)

  • 1. Impact of a computerized distress intolerance intervention on electrocortical reactivity to cannabis and threat cues: A randomized controlled trial.
    Macatee RJ; Preston TJ; Afshar K; Schmidt NB; Cougle JR
    Psychol Addict Behav; 2022 Nov; 36(7):920-929. PubMed ID: 35129994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distress intolerance moderation of motivated attention to cannabis and negative stimuli after induced stress among cannabis users: an ERP study.
    Macatee RJ; Okey SA; Albanese BJ; Schmidt NB; Cougle JR
    Addict Biol; 2019 Jul; 24(4):717-729. PubMed ID: 29737034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distress intolerance moderation of neurophysiological markers of response inhibition after induced stress: Relations with cannabis use disorder.
    Macatee RJ; Albanese BJ; Crane NA; Okey SA; Cougle JR; Schmidt NB
    Psychol Addict Behav; 2018 Dec; 32(8):944-955. PubMed ID: 30407026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal stability of neurophysiological drug cue reactivity before and after acute stress in cannabis users: A test of incentive sensitization.
    Macatee RJ; Preston TJ; Afshar K; Blaine SK; Schermitzler B
    Drug Alcohol Depend; 2023 Jun; 247():109862. PubMed ID: 37062250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological stress modulation of neural drug cue reactivity in cannabis use disorder.
    Macatee RJ; Preston TJ; Afshar K; Blaine SK; Schermitzler BS
    Psychol Addict Behav; 2023 Dec; 37(8):1039-1051. PubMed ID: 37535554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a brief distress intolerance intervention on acute stress modulation of response inhibition neurophysiology in cannabis use disorder.
    Afshar K; Cougle JR; Schmidt NB; Macatee RJ
    Addict Behav; 2023 Dec; 147():107811. PubMed ID: 37517377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a computerized intervention for high distress intolerance on cannabis use outcomes: A randomized controlled trial.
    Macatee RJ; Albanese BJ; Okey SA; Afshar K; Carr M; Rosenthal MZ; Schmidt NB; Cougle JR
    J Subst Abuse Treat; 2021 Feb; 121():108194. PubMed ID: 33357604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological sex and hormonal contraceptive associations with drug cue reactivity in cannabis use disorder.
    Macatee RJ; Cannon MJ; Schermitzler BS; Preston TJ; Afshar K
    J Psychiatr Res; 2024 Jun; 174():121-128. PubMed ID: 38626562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decomposing the late positive potential to cannabis cues in regular cannabis users: A temporal-spatial principal component analysis.
    Preston TJ; Cougle JR; Schmidt NB; Macatee RJ
    Psychophysiology; 2024 Apr; 61(4):e14471. PubMed ID: 37937737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated cognitive-behavioral therapy for comorbid cannabis use and anxiety disorders: The impact of severity of cannabis use.
    Buckner JD; Morris PE; Zvolensky MJ
    Exp Clin Psychopharmacol; 2021 Jun; 29(3):272-278. PubMed ID: 34264732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal course of mental health symptoms among veterans with and without cannabis use disorder.
    Livingston NA; Farmer SL; Mahoney CT; Marx BP; Keane TM
    Psychol Addict Behav; 2022 Mar; 36(2):131-143. PubMed ID: 34351175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting maladaptive reactivity to negative affect in emerging adults with cannabis use disorder: A preliminary test and proof of concept.
    Wolitzky-Taylor K; Glasner S; Tanner A; Ghahremani DG; London ED
    Behav Res Ther; 2022 Mar; 150():104032. PubMed ID: 35032700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing attentional bias and inhibitory control in cannabis use disorder using an eye-tracking paradigm with personalized stimuli.
    Yoon JH; San Miguel GG; Vincent JN; Suchting R; Haliwa I; Weaver MF; Schmitz JM; Lane SD
    Exp Clin Psychopharmacol; 2019 Dec; 27(6):578-587. PubMed ID: 30907601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Recreational Marijuana Legalization in the United States and Changes in Marijuana Use and Cannabis Use Disorder From 2008 to 2016.
    Cerdá M; Mauro C; Hamilton A; Levy NS; Santaella-Tenorio J; Hasin D; Wall MM; Keyes KM; Martins SS
    JAMA Psychiatry; 2020 Feb; 77(2):165-171. PubMed ID: 31722000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural and behavioral correlates of attentional bias to cannabis cues among adults with cannabis use disorders.
    Ruglass LM; Shevorykin A; Dambreville N; Melara RD
    Psychol Addict Behav; 2019 Feb; 33(1):69-80. PubMed ID: 30589308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in cannabis use disorder by cigarette smoking status in the United States, 2002-2016.
    Weinberger AH; Pacek LR; Wall MM; Zvolensky MJ; Copeland J; Galea S; Nahvi S; Moeller SJ; Hasin DS; Goodwin RD
    Drug Alcohol Depend; 2018 Oct; 191():45-51. PubMed ID: 30077055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Who responds best to text-delivered cannabis use disorder treatment? A randomized clinical trial with young adults.
    Mason MJ; Zaharakis NM; Moore M; Brown A; Garcia C; Seibers A; Stephens C
    Psychol Addict Behav; 2018 Nov; 32(7):699-709. PubMed ID: 30265057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical conditions of primary care patients with documented cannabis use and cannabis use disorder in electronic health records: a case control study from an academic health system in a medical marijuana state.
    Padwa H; Huang D; Mooney L; Grella CE; Urada D; Bell DS; Bass B; Boustead AE
    Subst Abuse Treat Prev Policy; 2022 May; 17(1):36. PubMed ID: 35527269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of acute stress on neural indices of positive and negative reinforcement processing in cannabis users.
    Preston TJ; Albanese BJ; Schmidt NB; Macatee RJ
    Psychol Addict Behav; 2022 Dec; 36(8):1036-1047. PubMed ID: 35696184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CannTeen Study: Cannabis use disorder, depression, anxiety, and psychotic-like symptoms in adolescent and adult cannabis users and age-matched controls.
    Lawn W; Mokrysz C; Lees R; Trinci K; Petrilli K; Skumlien M; Borissova A; Ofori S; Bird C; Jones G; Bloomfield MA; Das RK; Wall MB; Freeman TP; Curran HV
    J Psychopharmacol; 2022 Dec; 36(12):1350-1361. PubMed ID: 35772419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.